In a murine colon cancer-bearing mouse model, the combination of valsartan and anti-PD-1 mAb was shown to abolish the immunosuppressive TME and potentiate the CD8+ T-cell-mediated anti-tumor response. The gene discussed is CD8A; the disease is neoplasm.